Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>This study aimed to investigate the involvement of lncRNA CTBP1-AS2 in the progression of diabetic nephropathy (DN) by affecting high glucose (HG)-induced human glomerular mesangial cells (HGMCs).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>HGMCs were selected for the establishment of cell injury induced by HG. The expression of CTBP1-AS2, miR-155-5p and FOXO1 was detected by real-time PCR and western blotting. The target association between miR-155-5p and CTBP1-AS2 or FOXO1 was confirmed by dual-luciferase reporter assays. Cell proliferation and oxidative stress were revealed by CCK-8 colorimetry, and the measurement of reactive oxygen species (ROS) and the activities of antioxidant enzymes. Extracellular matrix (ECM) protein accumulation and the production of inflammatory cytokines were investigated by western blotting and ELISA.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The expression of CTBP1-AS2 was downregulated, and miR-155-5p was highly expressed in peripheral blood of DN patients and HG-treated HGMCs. Further investigation revealed that CTBP1-AS2 overexpression inhibited proliferation, oxidative stress, ECM accumulation and inflammatory response in HG-induced HGMCs. Mechanical analysis revealed that CTBP1-AS2 regulated FOXO1 expression via sponging miR-155-5p. Rescue experiments demonstrated that miR-155-5p overexpression or FOXO1 inhibition reversed the effects of CTBP1-AS2 in HG-stimulated HGMCs.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Taken together, this study revealed CTBP1-AS2 attenuated HG-induced HGMC proliferation, oxidative stress, ECM accumulation, and inflammation through miR-155-5p/FOXO1 signaling.</p>

What problem does this paper attempt to address?

This paper aims to explore the mechanism of long non - coding RNA (lncRNA) CTBP1 - AS2 in the progression of diabetic nephropathy (DN), especially how it affects the proliferation, oxidative stress, extracellular matrix (ECM) accumulation and inflammatory response of high - glucose (HG) - induced human glomerular mesangial cells (HGMCs). By studying the interaction between CTBP1 - AS2 and the miR - 155 - 5p/FOXO1 axis, the paper reveals that CTBP1 - AS2 acts as a competing endogenous RNA (ceRNA) of miR - 155 - 5p to up - regulate FOXO1 expression, thereby alleviating high - glucose - induced cell damage and providing a new potential target for the treatment of diabetic nephropathy. Specifically, the paper conducts research in the following aspects: 1. **Expression changes of CTBP1 - AS2**: The expression of CTBP1 - AS2 in the peripheral blood of DN patients and HGMCs treated with high glucose was detected, and it was found that its expression was significantly down - regulated. 2. **Functional verification of CTBP1 - AS2**: By over - expressing CTBP1 - AS2, its effects on the proliferation, oxidative stress, ECM accumulation and inflammatory response of HGMCs were observed. The results showed that CTBP1 - AS2 could inhibit these pathological processes. 3. **Exploration of molecular mechanisms**: Bioinformatics prediction and dual - luciferase reporter gene experiments were used to confirm the existence of binding sites between CTBP1 - AS2 and miR - 155 - 5p, and CTBP1 - AS2 up - regulates the expression of FOXO1 by sponging miR - 155 - 5p. 4. **Functional recovery experiments**: Further, by over - expressing miR - 155 - 5p or knocking down FOXO1, the key role of the miR - 155 - 5p/FOXO1 axis in the CTBP1 - AS2 regulatory pathway was verified, proving that the over - expression of miR - 155 - 5p or the knockdown of FOXO1 can reverse the protective effect of CTBP1 - AS2. In conclusion, this paper reveals that CTBP1 - AS2 inhibits high - glucose - induced HGMCs proliferation, oxidative stress, ECM accumulation and inflammatory response through the miR - 155 - 5p/FOXO1 signaling pathway, providing a new theoretical basis and potential target for the treatment of diabetic nephropathy.

LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p/FOXO1 axis

Effects of High Glucose, Tea Polyphenols on Mrna Expressions of Connective Tissue Growthfactor, Fibronectin in Human Mesangial Cells

Long non-coding RNA TTC28-AS1 attenuates high glucose-induced damage in HK-2 cells depending on the regulation of miR-320a/CD2AP axis

LncRNA NEAT1 Accelerates the Proliferation, Oxidative Stress, Inflammation, and Fibrosis and Suppresses the Apoptosis Through the miR-423-5p/GLIPR2 Axis in Diabetic Nephropathy

KCNQ1OT1/miR-18b/HMGA2 axis regulates high glucose-induced proliferation, oxidative stress, and extracellular matrix accumulation in mesangial cells

Silencing long noncoding RNA-CES1P1 suppresses glomerular endothelial cell inflammation in diabetic nephropathy

LncRNA HCP5 knockdown inhibits high glucose-induced excessive proliferation, fibrosis and inflammation of human glomerular mesangial cells by regulating the miR-93-5p/HMGA2 axis

LncRNA KCNQ1OT1 affects cell proliferation, apoptosis and fibrosis through regulating miR-18b-5p/SORBS2 axis and NF-ĸB pathway in diabetic nephropathy

CircTLK1 Downregulation Attenuates High Glucose-Induced Human Mesangial Cell Injury by Blocking the AKT/NF-κB Pathway Through Sponging miR-126-5p/miR-204-5p

Long noncoding RNA MIAT inhibits the progression of diabetic nephropathy and the activation of NF-κB pathway in high glucose-treated renal tubular epithelial cells by the miR-182-5p/GPRC5A axis

Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9

Postoperative extradural infusions in children: preliminary data from a comparison of bupivacaine/diamorphine with plain ropivacaine

[Prenatal diagnosis of spinal muscular atrophy (SMA) -- indications, restrictions, interpretation of results].

MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy

An On-Line Scheduling Heuristic With Better Worst Case Ratio Than Graham's List Scheduling

LncRNA KCNQ1OT1 promotes the development of diabetic nephropathy by regulating miR-93-5p/ROCK2 axis

LINC01232 targeting miR-1250-3p/MSH2 axis attenuates mesangial cell proliferation and fibrosis in diabetic nephropathy

Scanning Electrochemical Microscopy. 17. Studies of Enzyme-Mediator Kinetics for Membrane= and Surface- Immobilized Glucose Oxidase

LncRNA TUG1 Ameliorates Diabetic Nephropathy by Inhibiting Mir-21 to Promote TIMP3-expression.

Knockdown of circ_0003928 ameliorates high glucose-induced dysfunction of human tubular epithelial cells through the miR-506-3p/HDAC4 pathway in diabetic nephropathy

Studies in vitamin A; reactions of retinene1 with amino compounds.